Mycoses
📧 Sign up to get email alerts when something new happens for Mycoses.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-22EMA Authorised: Voriconazole Accord (voriconazole) — Accord Healthcare S.L.U.
The EMA authorised Voriconazole Accord (voriconazole) for treatment of fungal infections including Aspergillosis, Candidiasis, and Mycoses, …
-
EMA approval · 2026-07-21EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG
Pfizer's voriconazole (Vfend) has been authorised by EMA for use in fungal infections including candidiasis, mycoses, and aspergillosis.
-
EMA approval · 2026-07-01EMA Authorised: Noxafil (posaconazole) — Merck Sharp and Dohme B.V
EMA authorises Noxafil (posaconazole) for multiple fungal infections including candidiasis, mycoses, coccidioidomycosis, and aspergillosis.
-
EMA approval · 2026-04-28EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG
European Medicines Agency authorises Vfend (voriconazole) for fungal infections including candidiasis, mycoses, and aspergillosis.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Prospective Data Bank Creation to Study Vaginal Conditions
A prospective data bank study to investigate vaginal conditions (vulvodynia, bacterial vaginosis, mycoses, and preterm labor) is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-10-21EMA Authorised: Voriconazole Accord (voriconazole) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Voriconazole Accord (voriconazole) for treating aspergillosis, candidiasis and other mycoses; the m…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients [NA]
This clinical trial update reports the completion of a study evaluating anti-fungal strategies in patients with acute-on-chronic liver failu…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Liver Transplant European Study Into the Prevention of Fungal Infection [Phase 3]
Phase 3 European trial in liver transplant patients evaluated micafungin (Mycamine) for prevention of fungal infection; the study has comple…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for non-myeloablative allogeneic transplantation using TLI and ATG in patients with cutaneous T-cell lymphoma …
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis [Phase 3]
Phase 3 trial comparing rezafungin to caspofungin in candidemia and invasive candidiasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) [Phase 3]
A Phase 3 randomized study comparing fluconazole versus clotrimazole troches for preventing serious fungal infections in patients with AIDS …
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: A Study of Itraconazole in the Management of Superficial Fungal Infections in India [Phase 4]
Phase 4 clinical trial update for itraconazole in superficial fungal infections in India; study terminated.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections [Phase 2]
Phase 2 trial update comparing CD101 to standard of care for acute vulvovaginal candidiasis (yeast infection).
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Effect of Inflammation on Pharmacokinetics of Posaconazole
A completed clinical trial investigating how inflammation affects the pharmacokinetics of posaconazole.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations [Phase 4]
Phase 4 trial evaluating how weight and obesity influence anidulafungin drug concentrations; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: Bioequivalence Study for Terbinafine 250 mg [Phase 1]
GlaxoSmithKline completed a Phase 1 bioequivalence study of Terbinafine 250 mg for mycoses.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease [Phase 3]
Phase 3 clinical trial update on prophylaxis for mycoses in high-risk allogeneic stem cell transplant recipients with graft-versus-host dise…
-
CLINICAL_TRIALS withdrawal · 2015-08-25Clinical Trial Update: Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)
A Merck-sponsored clinical trial evaluating treatment and prophylaxis of invasive fungal infections in immunocompromised patients in Austria…
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: Iron Homoeostasis in Inflammation
Clinical trial on iron homeostasis in inflammatory and infectious conditions has completed, encompassing iron-deficiency anemia and iron ove…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT [Phase 4]
Phase 4 trial assessing antifungal effects of recombinant human GM-CSF in patients after allogeneic hematopoietic stem cell transplantation;…
-
CLINICAL_TRIALS research · 2012-07-18Clinical Trial Update: Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients [Phase 2]
A Phase 2 trial evaluating caspofungin as antifungal prophylaxis in high-risk liver transplant recipients to prevent fungal infections.
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: Pre-hospital Risk Factors for Invasive Fungal Infection
This clinical trial update discusses pre-hospital risk factors for invasive fungal infections in patients with acute myeloid leukemia and re…
-
EMA withdrawal · 2009-08-04EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe
EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation [Phase 4]
A Phase 4 study evaluating prophylactic itraconazole to prevent fungal infections in patients receiving high-dose chemotherapy and autologou…
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the safety of a single 5 mg dose of hLF1-11 in autologous hematopoietic stem cell transplant recipients.